Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD (BIgGII)
This study has been completed.
Study NCT00524004   Information provided by Johns Hopkins Bloomberg School of Public Health
First Received: August 31, 2007   Last Updated: November 26, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Travelers' Diarrhea
Additional conditions recognized in this trial
Dysentery
Giardiasis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Intestinal Diseases, Parasitic
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Interventions listed in this trial
Lacto-free milk supplement
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Johns Hopkins Bloomberg School of Public Health
Naval Medical Research Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services